Evidence map›Paper›PMID 34480728›Full record

ArticleClinical journal of gastroenterology2021

Olmesartan-associated sprue-like enteropathy diagnosed by capsule endoscopy and double balloon endoscopy.

Daisuke Taguchi, Takashi Ibuka, Masamichi Arao, Taku Mizutani, Noritaka Ozawa, Masaya Kubota, Yohei Shirakami, Makoto Shiraki, Hiroshi Araki, Masahito Shimizu

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Daisuke TaguchiDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu , Gifu, 501-1194, Japan. fiction_may_relieve@yahoo.co.jp.ORCID http://orcid.org/0000-0001-6626-7320
Takashi IbukaDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu , Gifu, 501-1194, Japan.
Masamichi AraoDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu , Gifu, 501-1194, Japan.
Taku MizutaniDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu , Gifu, 501-1194, Japan.
Noritaka OzawaDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu , Gifu, 501-1194, Japan.
Masaya KubotaDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu , Gifu, 501-1194, Japan.
Yohei ShirakamiDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu , Gifu, 501-1194, Japan.
Makoto ShirakiDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu , Gifu, 501-1194, Japan.
Hiroshi ArakiDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu , Gifu, 501-1194, Japan.
Masahito ShimizuDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu , Gifu, 501-1194, Japan.
Gifu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sprue-like enteropathy associated with olmesartan is characterized by villous atrophy in the duodenum. We report the case of an 81-year-old woman diagnosed with olmesartan-associated sprue-like enteropathy with no villous atrophy in the duodenum. The patient had been taking olmesartan for 10 years and complained of diarrhea and weight loss. Despite undergoing general treatment for 2 months, her symptoms showed no improvement. Gastrointestinal endoscopy and pathological findings showed no villous atrophy in the duodenum. However, villous atrophy was observed in the small intestine by capsule endoscopy. Pathological biopsy with double balloon endoscopy provided a definitive diagnosis. Diarrhea improved with the discontinuation of olmesartan and weight increased within a week of withdrawal. After the improvement of clinical symptoms, both endoscopic and pathological findings of villous atrophy in small intestine showed improvement.

Indexed as

Capsule EndoscopyCeliac DiseaseAged, 80 and overFemaleHumansImidazolesTetrazolesImidazolesolmesartanTetrazolesCapsule endoscopyDouble balloon endoscopyOlmesartanSprue-like enteropathyVillous atrophy

Identifiers

PMID34480728
OpenAlexW3196483337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.